Literature DB >> 9300457

[A case report of choroid plexus carcinoma].

K Araki1, T Aori, J A Takahashi, K Nozaki, I Nagata, H Kikuchi, M Yokoyama, H Hattori, Y Akiyama, Y Kubota, H Yokomizo.   

Abstract

Choroid plexus carcinoma (CPC) is a rare tumor with poor prognosis, whose optimal treatment has not yet been established. We report a case of a one-year-old infant who has been treated with successive combined therapy. The therapy involved two operations for partial removal, interrupted radiotherapy up to 12Gy, 2 cycles of salvage chemotherapy, followed by an operation for total removal, and then a further 3 cycles of chemotherapy. CT scan after the preoperative salvage chemotherapy showed remarkable shrinkage of the residual tumor, which made operative procedure easier. The patient was disease-free for ten months after the last operation. Patients with combined preoperative chemotherapy and total resection seem to enjoy prolonged progression-free survival, so preoperative chemotherapy for choroid plexus carcinoma seems to be of benefit, despite the fact that its optimal recipe has not yet been established.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9300457

Source DB:  PubMed          Journal:  No Shinkei Geka        ISSN: 0301-2603


  3 in total

Review 1.  Surgical treatment of brain tumors in infants younger than six months of age and review of the literature.

Authors:  Shih-Shan Lang; Lauren A Beslow; Brandon Gabel; Alex R Judkins; Michael J Fisher; Leslie N Sutton; Phillip B Storm; Gregory G Heuer
Journal:  World Neurosurg       Date:  2011-11-07       Impact factor: 2.104

2.  Surgical treatment for choroid plexus tumors in the fourth ventricle: brain stem infiltration hinders total extirpation.

Authors:  Toshihiro Kumabe; Miki Fujimura; Hidefumi Jokura; Teiji Tominaga
Journal:  Neurosurg Rev       Date:  2007-10-03       Impact factor: 3.042

Review 3.  Current management of choroid plexus carcinomas.

Authors:  Matthew Z Sun; Michael C Oh; Michael E Ivan; Gurvinder Kaur; Michael Safaee; Joseph M Kim; Joanna J Phillips; Kurtis I Auguste; Andrew T Parsa
Journal:  Neurosurg Rev       Date:  2013-09-26       Impact factor: 3.042

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.